Literature DB >> 19035299

Anticancer activity of novel extracts from Cautleya gracilis (Smith) Dandy: apoptosis in human medullary thyroid carcinoma cells.

Zengxia Li1, Sonja Sturm, Bernhard Svejda, Harald Höger, Elisabeth Schraml, Elisabeth Ingolic, Veronika Siegl, Hermann Stuppner, Roswitha Pfragner.   

Abstract

BACKGROUND: Medullary thyroid carcinoma (MTC) is a calcitonin-producing tumor of the thyroid arising from the parafollicular C-cells. MTC is poorly responsive to chemotherapy and radiotherapy, hence the only effective therapy is surgery. Based on this fact, alternative strategies have been sought.
MATERIALS AND METHODS: The effects of Cautleya gracilis (Smith) Dandy were investigated for the first time in three human MTC cell lines and in MTC-transplanted mice. Proliferation and viability were quantified by cell counting, WST-1 tests, and ATP luminescent cell viability assays. Apoptosis was studied by DAPI staining, flow cytometry and luminescent assays for caspases 3/7, 8 and 9.
RESULTS: A dose-dependent reduction of proliferation and an induction of apoptosis were found in all MTC cell lines, while normal fibroblasts were not impaired. Similar tumor inhibition was seen in heterotransplanted mice.
CONCLUSION: Our in vitro and in vivo findings suggest a new potential clinical effect of Cautleya.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19035299

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Ursolic acid from Trailliaedoxa gracilis induces apoptosis in medullary thyroid carcinoma cells.

Authors:  Victor Aguiriano-Moser; Bernhard Svejda; Zeng-Xia Li; Sonja Sturm; Hermann Stuppner; Elisabeth Ingolic; Harald Höger; Veronika Siegl; Nathalie Meier-Allard; Anton Sadjak; Roswitha Pfragner
Journal:  Mol Med Rep       Date:  2015-07-07       Impact factor: 2.952

2.  The complete chloroplast genome sequence of Cautleya gracilis.

Authors:  Yunqing Li; Yi Wang
Journal:  Mitochondrial DNA B Resour       Date:  2019-11-12       Impact factor: 0.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.